You are here: Industry Insights > Biopharma

News List

Freudenberg to introduce products in 2022 focussed on fluid-handling space for biopharma ExpressPharma
November 25, 2021
Freudenberg Medical has been serving biopharma customers directly, and with the help of a few distributors in India for the past few years, supplying standard and custom silicone tubings and fluid-handling products...
Lonza extends collaboration with biopharma client for antibody drug conjugate supply expresspharma
July 19, 2021
Lonza Group has extended collaboration with a major biopharma industry client for the supply of an antibody drug conjugate (ADC) against hard-to-treat cancers, the company said in a statement.
NIIMBL Announces $4.6M to Fund 10 New Biopharmaceutical Manufacturing Projects americanpharmaceuticalreview
June 10, 2021
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced funding for 10 new projects in technology, workforce development, and their Global Health Fund initiative, resulting from the Institute's Project Call 4.1 ...
Charnwood Molecular Plans Significant Expansion contractpharma
April 29, 2021
Charnwood Molecular, a UK-based preclinical discovery CRO servicing the global pharmaceutical and biopharma market, is planning a significant expansion in 2021.
Cytiva and Longitude (a Financial Times company) reveal five major challenges for the industry in new Global Biopharma Resilience Index prnasia
March 09, 2021
Global life sciences leader Cytiva, along with the Financial Times' research arm Longitude, have compiled a global index, ranking the ability of the biopharma industry to respond to five major challenges; in supply chain, talent, research and ...
High Purity New England Bolsters Biopharma Solutions Services contractpharma
February 26, 2021
High Purity New England (HPNE), a manufacturer and distributor of solutions for the biopharma industry, has introduced a highly customizable bioreactor line from BioStream International for the North American market.
Value of pharma’s M&A deals remain high, despite COVID-19 europeanpharmaceuticalreview
January 11, 2021
Analysts say M&A deals continue to be a core driver of pharma/biopharma industry growth and that 2021 will likely be another year of high deal value.
Healthcare industry records 103 deals worth $55.3 billion in December 2020 expresspharma
January 08, 2021
One big-ticket deal contributes 70.5 per cent of the total deal value in December 2020.
Agilent confers Thought Leader Award to IIT Delhi Scientist Professor Anurag Rathore expresspharma
December 08, 2020
Prof Rathore, the first researcher in India to receive this award; has been recognised for his contributions to biopharma research.
Regeneron named top biopharma company to work for europeanpharmaceuticalreview
November 04, 2020
According to Regeneron, it has placed either first or second in the same ranking for the past ten years, making it the most highly ranked company of the decade.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page